Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026)
Scynexis' (SCYX) quarterly Change in Acquisitions & Divestments came in at $11.5 million in Q2 2026, up 1.61% on a YoY basis from $11.3 million in Q2 2025, and up 316.55% quarter-over-quarter from $2.8 million in Q1 2026.
Analysis
Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Scynexis (SCYX) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $11.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Acquisitions & Divestments rose 1.61% year-over-year to $11.5 million; the trailing twelve-month figure through Jun 2026 stood at $33.7 million (down 30.85% YoY), and the FY2025 full-year result was $43.2 million, up 1.51% from the prior year.
- Change in Acquisitions & Divestments climbed to $11.5 million in Q2 2026 per SCYX's latest filing, from $2.8 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $20.6 million in Q2 2023 and bottomed at $2.8 million in Q1 2026.
- Historically, Change in Acquisitions & Divestments has averaged $11.6 million across 4 years, with a median of $11.3 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments jumped 56.2% in 2025, then slumped 77.89% in 2026.
- Over 4 years, Change in Acquisitions & Divestments stood at $10.1 million in 2023, then plunged by 42.16% to $5.8 million in 2024, then advanced by 21.74% to $7.1 million in 2025, then surged by 61.82% to $11.5 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $11.5 million, $2.8 million, and $7.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.46 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Sep 30, 2025 | 12.42 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Sep 30, 2024 | 19.21 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 10.05 Mn |
| Sep 30, 2023 | 19.99 Mn |
| Jun 30, 2023 | 20.56 Mn |
| Sep 30, 2020 | 3.57 Mn |
| Jun 30, 2020 | 10.67 Mn |
| Mar 31, 2020 | 6.48 Mn |
| Dec 31, 2019 | 11.04 Mn |
| Sep 30, 2019 | 11.50 Mn |
| Jun 30, 2019 | 18.56 Mn |
| Mar 31, 2019 | 24.64 Mn |